Closing the Vaccine Gap
Here, we explore some of the reasons behind vaccine hesitancy and highlight potential ways to combat the issue.
COVID-19 Childhood Vaccines: Why Don’t They Last a Lifetime, Like the Measles Shot?
Sophie Prosolek explores why some vaccines last a lifetime, while others do not, for Technology Networks.
Designing Vaccines With Reverse Vaccinology
Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen.
The Omicron Variant Highlights the Need for Smarter, Future-Proof Vaccine Design
Investment in vaccine science and technology development can provide us with the tools to respond to pathogens with pandemic potential. In this opinion article, Ariana Gomes discusses the use of AI for creating universal vaccines.
Vaccines: Just Add Water
Cold-chain distribution requirements complicate vaccine access, reducing vaccination rates for life-threatening, but preventable diseases. Now, researchers have developed a portable production platform for shelf-stable, antibacterial vaccines.
A Next-Generation SARS-CoV-2 Vaccine
A naturally occurring nanoparticle yields a new type of vaccine that offers broad-acting protection against emerging SARS-CoV-2 variants. With further development, the approach may lead to a pan-coronavirus vaccine.
Progress Towards a Mucosal Vaccine for Pneumonia
In a new study, researchers describe a subunit mucosal vaccine that induces broadly protective immunity against Klebsiella pneumoniae strains. Technology Networks interviewed author Jay Kolls to learn more about the findings and their significance.
Nanoparticles – Enabling Innovation in Vaccine Design
Nanoparticle-based vaccines have emerged as a potential alternative to conventional and subunit vaccines. This article explores the various properties and advantages of nanoparticles which allow the design of vaccines with enhanced antigen presentation and strong immunogenicity.
The Biotech Boom: Making Light Work of Market Access
This article outlines a five-step plan to help biotechs and biological pharma companies cut through the market complexities to get their new products to market swiftly and cost-efficiently.
Liquid Chromatography in the Biopharmaceutical Industry
Biopharmaceuticals have become invaluable tools for the treatment of a variety of diseases. Learn about the role liquid chromatography is playing in ensuring their efficacy, safety and stability, and the challenges these molecules pose for analysts.